Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).

Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, Ding WB, Li WH, Huang JH, Mu W, Gu SZ, Li JP, Zhao H, Wen SW, Lei YM, Song YS, Yuan CW, Wang WD, Huang M, Zhao W, Wu JB, Wang S, Zhu X, Han JJ, Ren WX, Lu ZM, Xing WG, Fan Y, Lin HL, Zhang ZS, Xu GH, Hu WH, Tu Q, Su HY, Zheng CS, Chen Y, Zhao XY, Fang ZT, Wang Q, Zhao JW, Xu AB, Xu J, Wu QH, Niu HZ, Wang J, Dai F, Feng DP, Li QD, Shi RS, Li JR, Yang G, Shi HB, Ji JS, Liu YE, Cai Z, Yang P, Zhao Y, Zhu XL, Lu LG, Teng GJ, CHANCE001 Investigators

Open source

DOI
10.1038/s41392-022-01235-0
Published
2023 Feb 8
Container
Signal transduction and targeted therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41392-022-01235-0,
  title = {Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).},
  author = {Zhu HD and Li HL and Huang MS and Yang WZ and Yin GW and Zhong BY and Sun JH and Jin ZC and Chen JJ and Ge NJ and Ding WB and Li WH and Huang JH and Mu W and Gu SZ and Li JP and Zhao H and Wen SW and Lei YM and Song YS and Yuan CW and Wang WD and Huang M and Zhao W and Wu JB and Wang S and Zhu X and Han JJ and Ren WX and Lu ZM and Xing WG and Fan Y and Lin HL and Zhang ZS and Xu GH and Hu WH and Tu Q and Su HY and Zheng CS and Chen Y and Zhao XY and Fang ZT and Wang Q and Zhao JW and Xu AB and Xu J and Wu QH and Niu HZ and Wang J and Dai F and Feng DP and Li QD and Shi RS and Li JR and Yang G and Shi HB and Ji JS and Liu YE and Cai Z and Yang P and Zhao Y and Zhu XL and Lu LG and Teng GJ and CHANCE001 Investigators},
  year = {2023},
  journal = {Signal transduction and targeted therapy},
  doi = {10.1038/s41392-022-01235-0},
  url = {https://doi.org/10.1038/s41392-022-01235-0}
}

RIS

TY  - JOUR
TI  - Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
AU  - Zhu HD
AU  - Li HL
AU  - Huang MS
AU  - Yang WZ
AU  - Yin GW
AU  - Zhong BY
AU  - Sun JH
AU  - Jin ZC
AU  - Chen JJ
AU  - Ge NJ
AU  - Ding WB
AU  - Li WH
AU  - Huang JH
AU  - Mu W
AU  - Gu SZ
AU  - Li JP
AU  - Zhao H
AU  - Wen SW
AU  - Lei YM
AU  - Song YS
AU  - Yuan CW
AU  - Wang WD
AU  - Huang M
AU  - Zhao W
AU  - Wu JB
AU  - Wang S
AU  - Zhu X
AU  - Han JJ
AU  - Ren WX
AU  - Lu ZM
AU  - Xing WG
AU  - Fan Y
AU  - Lin HL
AU  - Zhang ZS
AU  - Xu GH
AU  - Hu WH
AU  - Tu Q
AU  - Su HY
AU  - Zheng CS
AU  - Chen Y
AU  - Zhao XY
AU  - Fang ZT
AU  - Wang Q
AU  - Zhao JW
AU  - Xu AB
AU  - Xu J
AU  - Wu QH
AU  - Niu HZ
AU  - Wang J
AU  - Dai F
AU  - Feng DP
AU  - Li QD
AU  - Shi RS
AU  - Li JR
AU  - Yang G
AU  - Shi HB
AU  - Ji JS
AU  - Liu YE
AU  - Cai Z
AU  - Yang P
AU  - Zhao Y
AU  - Zhu XL
AU  - Lu LG
AU  - Teng GJ
AU  - CHANCE001 Investigators
PY  - 2023
JO  - Signal transduction and targeted therapy
DO  - 10.1038/s41392-022-01235-0
UR  - https://doi.org/10.1038/s41392-022-01235-0
ER  -

APA

HD, Z., HL, L., MS, H., WZ, Y., GW, Y., BY, Z., JH, S., ZC, J., JJ, C., NJ, G., WB, D., WH, L., JH, H., W, M., SZ, G., JP, L., H, Z., SW, W., YM, L., YS, S., CW, Y., WD, W., M, H., W, Z., JB, W., S, W., X, Z., JJ, H., WX, R., ZM, L., WG, X., Y, F., HL, L., ZS, Z., GH, X., WH, H., Q, T., HY, S., CS, Z., Y, C., XY, Z., ZT, F., Q, W., JW, Z., AB, X., J, X., QH, W., HZ, N., J, W., F, D., DP, F., QD, L., RS, S., JR, L., G, Y., HB, S., JS, J., YE, L., Z, C., P, Y., Y, Z., XL, Z., LG, L., GJ, T., & Investigators, C. (2023). Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-022-01235-0

Source records